Stress & mood evidence brief
SAMe is a compound involved in methylation pathways and neurotransmitter metabolism. Supplements are usually used for mood and joint comfort, but medication interactions are central.
SAMe has research in depression and osteoarthritis, but interaction risk and mixed evidence make it unsuitable as a casual mood or joint recommendation.
Depression reviews find possible benefit, while Cochrane osteoarthritis evidence remains limited by small and older trials.
Clinical trials use varied oral dosing and formulations; users should not combine it with antidepressants or serotonergic drugs without clinical guidance.
May trigger anxiety, insomnia, mania in bipolar disorder, or serotonin-related interactions. Mental health symptoms deserve clinical care.
Source Drawer
The score reflects evidence that the supplement does its stated job. Some jobs are direct, such as strength, endurance, or recovery; others are indirect, such as sleep, mood, appetite, or health support. A real effect can still receive a cautious practical rating when dose, safety, product quality, or audience fit remain uncertain.
Send the disputed claim, source link, and why it changes the practical verdict. Corrections that materially affect the claim, dose, caveat, or rating are prioritized.
Report a source or rating issue